- Page 2:
Beyond Bioethics: A Proposal for Mo
- Page 5 and 6:
(ARTs) as well as laboratory resear
- Page 7 and 8:
issues raised by new biotechnologie
- Page 9 and 10:
human and animals cells, tissues, a
- Page 11 and 12:
(CLIA) of 1988 and, more importantl
- Page 13 and 14:
the activities of both private and
- Page 15 and 16:
themselves whether or not to eat fo
- Page 17 and 18:
5.5 Creating a New Regulatory Insti
- Page 19 and 20:
egarding reproductive biomedicine t
- Page 21 and 22:
to represent constituencies that ar
- Page 23 and 24:
“Deliberative panels,” the term
- Page 25 and 26:
participants may be able to engage
- Page 27 and 28:
outer limits of the right to privac
- Page 30:
About the Authors Francis Fukuyama
- Page 33 and 34:
1.1 THE CHALLENGE OF NEW BIOTECHNOL
- Page 35 and 36:
7.1 TRADITIONAL REPRODUCTIVE TECHNO
- Page 37 and 38:
Shortness as a Psychological and So
- Page 40 and 41:
1 Introduction This report presents
- Page 42 and 43:
them only on the basis of safety an
- Page 44 and 45:
esearch, and clinical and medical p
- Page 46 and 47:
Congress’ powers over scientific
- Page 48 and 49:
of newborns; destruction of an embr
- Page 50:
1.6 Bibliography Evans, John H. Pla
- Page 53 and 54:
endogenous growth hormone secretion
- Page 55 and 56:
slippery slope toward blanket uses
- Page 57 and 58:
proposed by Eli Lilly - a rather su
- Page 59 and 60:
Committee tended, predictably, to r
- Page 61 and 62:
coincidentally, she was also one of
- Page 64:
2.5 Bibliography American Academy o
- Page 67 and 68:
• Limits on the commercialization
- Page 69 and 70:
the sick and relieving the pain and
- Page 71 and 72:
give for opposing this practice var
- Page 73 and 74:
We recognize that for some people,
- Page 76:
3.6 Bibliography Baruch, Susannah,
- Page 79 and 80:
taxonomies are likely to exist. For
- Page 81 and 82:
that an investigator may not be abl
- Page 83 and 84:
ecome part of this complex transact
- Page 85 and 86:
These concerns are not unfounded, a
- Page 87 and 88:
cryopreservation a good example of
- Page 89 and 90:
A 2003 news story published in Popu
- Page 91 and 92:
episode. Reputational incentives ar
- Page 93 and 94:
Would you approve or disapprove if
- Page 95 and 96:
strong preference for a mixed famil
- Page 97 and 98:
controversial not because it provid
- Page 99 and 100:
esearch. On the other end are situa
- Page 101 and 102:
nucleus of a somatic cell, such as
- Page 103 and 104:
And we have to have some degree - a
- Page 105 and 106:
father. The experiment could also l
- Page 107 and 108:
The availability of oocytes in larg
- Page 109 and 110:
and the tail of serpent. In biology
- Page 111 and 112:
our view, that the scientific commu
- Page 113 and 114:
Bonnicksen, Andrea. "Innovative ART
- Page 115 and 116:
Kubawara, Y., T. Okai, S. Kozuma, N
- Page 117 and 118:
Shamblott, Michael J., Joyce Axelma
- Page 119 and 120:
116
- Page 121 and 122:
iotech companies or university clin
- Page 123 and 124:
As an infrastructure of quality ass
- Page 125 and 126:
toward implementing a comprehensive
- Page 127 and 128:
clinical research, 22 while the FDA
- Page 129 and 130:
principles of good governance as fe
- Page 131 and 132:
sustainable way. Examples include c
- Page 133 and 134:
cloning to register with the Depart
- Page 135 and 136:
kind of cloning or they limit the b
- Page 137 and 138:
The federal government has been rel
- Page 139 and 140:
includes ethicists, scientists, men
- Page 141 and 142:
Society for Assisted Reproductive T
- Page 143 and 144:
Reproductive Endocrinology Subspeci
- Page 145 and 146:
safety guidelines aimed at ranking
- Page 147 and 148:
elatively mundane. 67 For example,
- Page 149 and 150:
Fallon, Peter, and Zafiris Tzannato
- Page 151 and 152:
148
- Page 153 and 154:
6.1 Italy - from the “Wild West
- Page 155 and 156:
also prohibited. 13 The law activel
- Page 157 and 158:
selection technologies, but only fo
- Page 159 and 160:
eproductive technologies in section
- Page 161 and 162:
Neither the RIHEA nor its explanato
- Page 163 and 164:
inspect all licensees, or how often
- Page 165 and 166:
(principle (e)). 43 Canada affords
- Page 167 and 168:
traditional views of reproduction,
- Page 169 and 170:
y the Canadian authorities and the
- Page 171 and 172:
esearch on human embryos. It requir
- Page 173 and 174:
This argument is not likely to conv
- Page 175 and 176:
• Maintain a formal register of i
- Page 177 and 178:
The remaining three positions reser
- Page 179 and 180:
type of research. The HFEA is requi
- Page 181 and 182:
The relevance of the Code of Practi
- Page 183 and 184:
180
- Page 185 and 186:
182
- Page 187 and 188:
of saving the life of an older sibl
- Page 189 and 190:
procreative right, unlikely as it i
- Page 191 and 192:
assisted suicide, the Court has est
- Page 193 and 194:
or that there are an infinite numbe
- Page 195 and 196:
What is obvious is that the Court s
- Page 197 and 198:
generalizing from a strong but gene
- Page 199 and 200:
are not any societal traditions tha
- Page 201 and 202:
the First Amendment’s protection
- Page 203 and 204:
least preferable among all forms of
- Page 205 and 206:
Surrogacy 16 Donor egg 14 Donor spe
- Page 207 and 208:
To recap, the survey data shows a s
- Page 209 and 210:
Robertson, John A. Children of Choi
- Page 211 and 212:
media and from polling organization
- Page 213 and 214:
Before diving into the data, the me
- Page 215 and 216:
(126), and allowing parents to have
- Page 217 and 218:
esearch cloning. Two questions (150
- Page 219 and 220:
asked five times whether the public
- Page 221 and 222:
the creation of embryos solely for
- Page 223 and 224:
Our conclusions could be criticized
- Page 225 and 226:
about embryonic stem cells? The ans
- Page 227 and 228:
were essentially split (44 percent
- Page 229 and 230:
226
- Page 231 and 232:
228
- Page 233 and 234:
coincidence that U.S. scientists id
- Page 235 and 236:
assertion of jurisdiction in this c
- Page 237 and 238:
of the opposition to genetically mo
- Page 239 and 240:
More generally, it is shortsighted
- Page 241 and 242:
Process.” 19 According to their i
- Page 243 and 244: another branch of medicine. ART pra
- Page 245 and 246: 242
- Page 247 and 248: Navasky, Victor S., and Christopher
- Page 249 and 250: to extract benefits for their membe
- Page 251 and 252: entails. 3 CAMR, a very large and h
- Page 253 and 254: of scientists in these debates woul
- Page 255 and 256: elatively modest. Canada and Austra
- Page 257 and 258: ighteous manner, justifying their c
- Page 259 and 260: eaching out to the public, the agen
- Page 261 and 262: ultimately benefits more the patien
- Page 263 and 264: In many cases, these efforts are pe
- Page 265 and 266: The rationale for including stakeho
- Page 267 and 268: years away. Again, no scientific ba
- Page 269 and 270: The view that deliberation can shar
- Page 271 and 272: members and instructed to reach con
- Page 273 and 274: Deliberation: This requirement has
- Page 275 and 276: One may wonder why public hearings
- Page 277 and 278: conference. Denmark is the clear le
- Page 279 and 280: legislative and regulatory process.
- Page 281 and 282: 10.9.1 The National Environmental P
- Page 283 and 284: considered in the process, identify
- Page 285 and 286: vicinity of black residential areas
- Page 287 and 288: it significantly constraints the ag
- Page 289 and 290: 286
- Page 291 and 292: Dunkerley, David, and Peter Glasner
- Page 293: ———. "The Courts and the Ossi
- Page 297 and 298: agency’s ability to implement Con
- Page 299 and 300: areas that were thought to require
- Page 301 and 302: Small decision-making bodies such a
- Page 303 and 304: accountability also comes the very
- Page 305 and 306: and remains the British solution to
- Page 307 and 308: equirement is very difficult to imp
- Page 309 and 310: advisory board, the higher the chan
- Page 311 and 312: 11.2.2 The Advisory Board as a Boar
- Page 313 and 314: suggesting candidates. They include
- Page 315 and 316: 312
- Page 317 and 318: Morrison, Alan B. "How Independent
- Page 319 and 320: 12.1 Deliberative Panels Deliberati
- Page 321 and 322: complexity would be to convene deli
- Page 323 and 324: deliberative panels, however, delib
- Page 325 and 326: Participation suffered from conside
- Page 327 and 328: 12.3 Public Consultation and Rule-M
- Page 329 and 330: divide the public, it is quite unli
- Page 331 and 332: 328
- Page 333 and 334: Among the parties subject to record
- Page 335 and 336: demand in-depth health screening, a
- Page 337 and 338: many prospective parents are attrac
- Page 339 and 340: Traditionally, the practice of medi
- Page 341 and 342: eliefs firmly held by medical pract
- Page 343 and 344: some studies, the TRI program has b
- Page 345 and 346:
13.4 Technologies of Reproductive C
- Page 347 and 348:
epresentatives of the general publi
- Page 349 and 350:
population of firms, clinics, labor
- Page 351 and 352:
an ART program, a biotech company,
- Page 353 and 354:
By all accounts, the British regula
- Page 355 and 356:
would add roughly 0.56 percent to t
- Page 357 and 358:
[cited September 20, 2005]. Availab